Table 4.
Descriptive statistics for the superficial FAZ in the study participants by selected clinical conditions (n = 28).
| Investigated Trait | Statistical Parameter | p-Value | |
|---|---|---|---|
| M (SD) | Me (Q1–Q3) | ||
| Localized scleroderma | 0.271 (0.084) | 0.270 (0.240–0.345) | =0.6331 |
| Systemic scleroderma | 0.255 (0.115) | 0.250 (0.150–0.330) | |
| Scleroderma pattern: | =0.0104 | ||
| ● Early | 0.399 (0.073) | 0.390 (0.350–0.445) | |
| ● Active | 0.239 (0.088) | 0.250 (0.150–0.300) | |
| ● Late * | 0.222 (0.089) | 0.230 (0.140–0.280) | |
| SCI70 | 0.256 (0.121) | 0.245 (0.145–0.350) | =0.6184 |
| Centromere | 0.271 (0.084) | 0.270 (0.240–0.345) | |
| Number of vessels: | =0.4979 | ||
| ● Normal | 0.322 (0.080) | 0.315 (0.255–0.390) | |
| ● Reduced | 0.260 (0.112) | 0.260 (0.160–0.345) | |
| ● Very reduced | 0.237 (0.080) | 0.240 (0.220–0.280) | |
| Avascular areas: | =0.7091 | ||
| ● Yes | 0.255 (0.100) | 0.275 (0.155–0.340) | |
| ● No | 0.267 (0.111) | 0.250 (0.180–0.340) | |
| Giant capillaries: | =0.1753 | ||
| ● Yes | 0.239 (0.086) | 0.250 (0.150–0.300) | |
| ● No | 0.282 (0.117) | 0.270 (0.180–0.380) | |
| Hemorrhages: | =0.0198 | ||
| ● Yes | 0.216 (0.087) | 0.225 (0.135–0.280) | |
| ● No | 0.285 (0.106) | 0.270 (0.230–0.350) | |
| Branched vessels: | =0.7631 | ||
| ● Yes | 0.268 (0.100) | 0.270 (0.180–0.350) | |
| ● No | 0.257 (0.107) | 0.250 (0.175–0.320) | |
| Interstitial lung disease: | =0.9067 | ||
| ● Yes | 0.258 (0.105) | 0.270 (0.150–0.350) | |
| ● No | 0.262 (0.106) | 0.250 (0.180–0.340) | |
| NSIP | 0.286 (0.102) | 0.270 (0.230–0.380) | =0.1248 |
| UIP | 0.185 (0.101) | 0.155 (0.120–0.250) | |
| MMF | 0.286 (0.118) | 0.270 (0.210–0.380) | =0.4313 |
| MTX | 0.238 (0.095) | 0.250 (0.140–0.300) | |
| Finger ulcers: | =0.4087 | ||
| ● Yes | 0.241 (0.105) | 0.250 (0.140–0.330) | |
| ● No | 0.269 (0.106) | 0.255 (0.180–0.350) | |
| Arterial hypertension: | =0.5162 | ||
| ● Yes | 0.242 (0.092) | 0.245 (0.140–0.340) | |
| ● No | 0.267 (0.111) | 0.270 (0.180–0.350) | |
| Administration of sildenafil: | =0.0178 | ||
| ● Yes | 0.218 (0.098) | 0.215 (0.140–0.300) | |
| ● No | 0.292 (0.103) | 0.280 (0.240–0.350) | |
| Administration of amlodipine: | =0.0626 | ||
| ● Yes | 0.292 (0.121) | 0.280 (0.180–0.380) | |
| ● No | 0.231 (0.083) | 0.240 (0.170–0.300) | |
M—mean; SD—standard deviation; Me—median; Q—quartile. * Scleroderma pattern, post-hoc multiple comparisons: early vs. active p < 0.0001; early vs. late p < 0.0001; active vs. late NS. Bold values indicate statistical significance.